Acne Medication
The Global Acne Medication Market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025 at a CAGR of 3.9% from 2018 to 2025. Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin.
The Global Acne Medication Market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025 at a CAGR of 3.9% from 2018 to 2025. Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Key Findings of <strong>Acne</strong> <strong>Medication</strong> Market<br />
Key Findings of the <strong>Acne</strong> <strong>Medication</strong> Market:<br />
The antibiotics segment accounted for nearly one-fourth share of the<br />
global acne medication market in 2017.<br />
The over-the-counter medicine segment is expected to grow at a CAGR of<br />
2.9% from 2018 to 2025.<br />
The non-inflammatory acne segment accounted for around two-fifths<br />
share of the global market in 2017.<br />
Europe accounted for around one-fourth share of the global market in<br />
2017.<br />
LAMEA is expected to provide lucrative market growth opportunities and<br />
grows with the CAGR of 4.5% from 2018 to 2025.
Change language